Impact of eculizumab on hospitalization rates and relapse treatment in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from the phase 3 PREVENT study

Tarih

2019

Yazar

Kim, H. J.
Pittock, S. J.
Berthele, A.
Fujihara, K.
Levy, M.
Palace, J.
Wingerchuk, D. M.

Üst veri

Tüm öğe kaydını göster

Özet

…

Kaynak

Multiple Sclerosis Journal

Cilt

25

Bağlantı

https://hdl.handle.net/20.500.12712/10620

Koleksiyonlar